Symbol | Exchange | Currency |
|---|
Redx Pharma plc is a United Kingdom-based company, which is focused on the discovery and development of novel medicines for the treatment of cancer and fibrotic diseases. The Company’s product pipeline includes RXC004 and ROC007. Its lead product candidate RXC004, which is a potent, selective, oral small molecule inhibitor of the enzyme, Porcupine, a key activator of Wnt ligands in the Wnt signalling pathway. RXC004 is in Phase I study in combination with nivolumab (OPDIVO- Bristol Myers Squibb, an anti-PD-1 antibody). The RXC007 is a selective small molecule inhibitor that targets Rho Associated Coiled-Coil Containing Protein Kinase 2 (ROCK2) which sits at a nodal point in a cell signaling pathway. RXC007 is used for the treatment of fibrotic diseases.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Sell | Buy |
| Technical Indicators | Strong Buy | Buy | Strong Buy | Strong Buy | Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Neutral | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 46.00 | 46.00 | 44.00 | -1.50 | -3.19% | 3.79M | London | |||
| 126.66 | 126.92 | 125.60 | +0.16 | +0.13% | 103.27M | London | |||
| 710.00 | 710.00 | 710.00 | -10.00 | -1.39% | 402.56K | London | |||
| 80.00 | 82.60 | 78.80 | -2.00 | -2.44% | 27.37M | London | |||
| 153.12 | 154.92 | 150.12 | -3.64 | -2.32% | 48.71M | London | |||
| 5.50 | 5.64 | 5.50 | -0.75 | -12.50% | 14.63M | London | |||
| 320.00 | 320.00 | 313.00 | -2.50 | -0.78% | 27.68K | London | |||
| 619.60 | 651.80 | 597.80 | -33.6 | -5.14% | 2.26M | London | |||
| 82.44 | 84.70 | 76.40 | +3.58 | +4.54% | 5.84M | London | |||
| 382.50 | 386.50 | 373.50 | -11.50 | -2.92% | 298.79K | London | |||
| 1,052.00 | 1,078.50 | 1,048.00 | -26.50 | -2.46% | 11.84M | London | |||
| 21.00 | 21.50 | 20.36 | -0.21 | -0.99% | 2.83M | London | |||
| 1,016.00 | 1,018.50 | 994.20 | -11.00 | -1.07% | 4.59M | London | |||
| 890.00 | 900.00 | 880.00 | -24.00 | -2.63% | 13.65K | London | |||
| 238.50 | 239.50 | 232.00 | -2.00 | -0.83% | 720.26K | London |